Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyi Sun

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2023
Oral Fungal Alterations in Patients with COVID-19 and Recovered PatientsXiaobo Hu, Haiyu Wang, Bo Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
Machine-Learning Microfluidic Minute-Scale Microorganism Metrics Monitoring(M6)Ning Yang, Jiahao Ding, Si Chen, et al.
Scientific Reports|January 16, 2026
Prediction of baseline oral microbiota for clinical classification post Omicron variant of SARS-CoV-2 infectionJunyi Sun, Shanshuo Liu, Daming Wang, et al.
Scientific Reports|March 31, 2025
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19Bohan Jia, Junyi Sun, Di Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
Cell Viability, Drug Screening, and Mechanism Study Under Mild Phototherapy Integrated Chemotherapy (PIC)Tongge Li, Shihui Wang, Qianhui Ling, et al.
Circulation|June 22, 2026
Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node CellsLu Ren, Nadjet Belbachir, Hao Zhang, et al.
Plos One|October 14, 2025
Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered casesFeng Gao, Daming Wang, Lihua Zuo, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 yearsBo Yu, Haiyu Wang, Guangming Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS-CoV-2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort StudyJunyi Sun, Mengzhao Yang, Guanyue Su, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World StudyRanran Sun, Haiyu Wang, Junyi Sun, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2023
Oral Fungal Alterations in Patients with COVID-19 and Recovered PatientsXiaobo Hu, Haiyu Wang, Bo Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 15, 2026
Machine-Learning Microfluidic Minute-Scale Microorganism Metrics Monitoring(M6)Ning Yang, Jiahao Ding, Si Chen, et al.
Scientific Reports|January 16, 2026
Prediction of baseline oral microbiota for clinical classification post Omicron variant of SARS-CoV-2 infectionJunyi Sun, Shanshuo Liu, Daming Wang, et al.
Scientific Reports|March 31, 2025
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19Bohan Jia, Junyi Sun, Di Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
Cell Viability, Drug Screening, and Mechanism Study Under Mild Phototherapy Integrated Chemotherapy (PIC)Tongge Li, Shihui Wang, Qianhui Ling, et al.
Circulation|June 22, 2026
Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node CellsLu Ren, Nadjet Belbachir, Hao Zhang, et al.
Plos One|October 14, 2025
Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered casesFeng Gao, Daming Wang, Lihua Zuo, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 yearsBo Yu, Haiyu Wang, Guangming Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS-CoV-2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort StudyJunyi Sun, Mengzhao Yang, Guanyue Su, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World StudyRanran Sun, Haiyu Wang, Junyi Sun, et al.
Pageof 7